RRML - VEGF-C and podoplanin, as biomarkers of sepsis. An experimental study
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2020): 1.027

Rejection rate (2020): 75%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- November 2021 -
 
Cell Cycle Regulatory CCND1 G8... 19
COVID-19 associated coagulopat... 19
Romanian Review of Laboratory ... 13
The Effect of Resveratrol on S... 11
Acquired Angioedema Due to C1 ... 10
Circulating amino acids as fin... 10
Mutations in the KRAS gene as ... 9
Evaluation of Plasma AA/DHA+EP... 6
Genetic Diagnostic Approaches ... 6
Atellica CH 930 chemistry anal... 6

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 29(4)/2021 DOI:10.2478/rrlm-2021-0030
XML
TXT

Research article

VEGF-C and podoplanin, as biomarkers of sepsis. An experimental study

Emoke Almasy, Janos Szederjesi, Bianca-Liana Grigorescu, Simona Gurzu, Alexandra Lazar, Gergo Raduly, Adrian Man, Madalina Oprica, Irina Saplacan, Sanda-Maria Copotoiu

Correspondence should be addressed to: Janos Szederjesi

Abstract:

Background: Sepsis is the leading cause of morbidity and mortality in intensive care units. This study explored the possible role of vascular endothelial growth factor-C (VEGF-C) and podoplanin (PDPN) in sepsis. Methods: 22 Wistar rats were divided into three groups: two experimental (Group A and B, n=8/8) and a control (Group C, n=6). Sepsis was induced with intraperitoneal injection of ESBL (extended-spectrum beta-lactamases)-producing E-coli live bacteria for group A and with lipopolysaccharide for group B. Sterile saline solution was injected for group C. Blood samples were collected after 24 hours to determine the serum level of VEGF-C, and PDPN expression was examined in liver, kidney, and lung tissues. Bacteremia was assessed for group A. Results: Higher serum levels of VEGF-C were found in Group A vs C (p=0.05) and group B vs. C (p=0.004), respectively.VEGF-C was also increased in animals with negative- vs. positive blood cultures from group A (p=0.04) and from group B vs. those with positive blood cultures from group A (p=0.03). High intensity of PDPN tissue expression was observed in the pulmonary alveolocytes from Group A and epithelium of the proximal renal tubules in groups B and C, compared to group A. Conclusions: Circulating VEGF-C can be succesfuly used as a biomarker of sepsis with negative blood cultures and high risk of renal failure, whereas PDPN seems to exert a protective role against lung injuries in live bacteria-induced sepsis.

Keywords: podoplanin, vascular endothelial growth factor, sepsis, lipopolysaccharide

Received: 1.9.2021
Accepted: 27.9.2021
Published: 1.10.2021

 
  PDF Download full text PDF
(3008 KB)
     
 
How to cite
Almasy E, Szederjesi J, Grigorescu BL, Gurzu S, Lazar A, Raduly G, et al. VEGF-C and podoplanin, as biomarkers of sepsis. An experimental study. Rev Romana Med Lab. 2021;29(4):403-12. DOI:10.2478/rrlm-2021-0030